SCIMAR LTD has a total of 11 patent applications. Its first patent ever was published in 2003. It filed its patents most often in Australia, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are PHARMAPRINT INC, BUCK ELIZABETH A and NORA THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Canada | 2 | |
#4 | China | 1 | |
#5 | United States | 1 | |
#6 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Peptides | |
#5 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Ming Zhi | 5 |
#2 | Lautt Wilfred Wayne | 5 |
#3 | Lautt W Wayne | 5 |
#4 | Wang Helen | 3 |
#5 | Lautt Wayne W | 1 |
#6 | Wang Dr Helen | 1 |
#7 | Macedo Paula | 1 |
Publication | Filing date | Title |
---|---|---|
AU2014202625A1 | Hepatic insulin sensitizing substance and test meal for insulin sensitization | |
CN103906521A | Use of s-adenosylmethionine, vitamin e, and vitamin c for the prevention and treatment of cardiovascular dysfunction |